Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
K
Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
TSX:GUD
Price:
11.27
CAD
-1.14%
Market Closed
Market Cap:
CA$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
CA |
|
G
|
Greif Inc
F:GR3
|
US |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
Wall St Price Targets
GUD Price Forecast
Based on 8 analysts
Based on 8 analysts
0% Downside
from
CA$11.27
today
Knight Therapeutics Inc (GUD)’s 12-month stock price forecast through October 2027 has a consensus target of CA$11.22, broadly in line with the current price. The forecast is based on price targets from 8 Wall Street analysts.
Knight Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GUD's stock price target?
Price Target
11.22
CAD
11.22
CAD
According to Wall Street analysts, the average 1-year price target for GUD is 11.22 CAD with a low forecast of 10.91 CAD and a high forecast of 14.7 CAD.
What is the Revenue forecast for Knight Therapeutics Inc?
Projected CAGR
7%
7%
Over the last 10 years, the compound annual growth rate for Revenue has been 84%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for Knight Therapeutics Inc?
Projected CAGR
9%
9%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 79%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Knight Therapeutics Inc?
Projected CAGR
101%
101%
The compound annual growth rate for Operating Income over the next 3 years is 101%.